Home › Essential Thrombocythemia › Utah › Salt Lake City
Essential Thrombocythemia clinical trials in Salt Lake City, UT
4 studies for Essential Thrombocythemia are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- Huntsman Cancer Institute At University of Utah, Salt Lake City
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Huntsman Cancer Institute At University of Utah, Salt Lake City
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Huntsman Cancer Institute, Salt Lake City
Essential Thrombocythemia trials in other cities
- New York City, NY7 studies
- Durham, NC6 studies
- Chicago, IL4 studies
- Mountain View, CA4 studies
- Nashville, TN4 studies
- Boston, MA4 studies
- Miami, FL4 studies
- Baltimore, MD4 studies
- Irvine, CA3 studies
- Los Angeles, CA3 studies
- Houston, TX3 studies
- Kansas City, MO3 studies
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.